Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

Nat Commun. 2022 Feb 11;13(1):835. doi: 10.1038/s41467-022-28389-3.

Abstract

The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA1 Protein / metabolism*
  • BRCA2 Protein / genetics
  • BRCA2 Protein / metabolism*
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Carcinoma, Ovarian Epithelial / genetics
  • Carcinoma, Ovarian Epithelial / immunology*
  • Cystadenocarcinoma, Serous / genetics
  • Cystadenocarcinoma, Serous / immunology*
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Genotype
  • Homologous Recombination
  • Humans
  • Mutation
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / immunology*
  • Prognosis
  • Proteomics
  • Tumor Microenvironment / immunology*

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human